This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
 
Though development of a next-generation DNA sequencing platform would appear to be a logical target for the collaboration between Agilent Technologies and BioNanomatrix announced last week, that particular application is not a priority, an Agilent official told BioCommerce Week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.